148 related articles for article (PubMed ID: 9539780)
41. Pharmacokinetics and biodistribution of a light-chain-shuffled CC49 single-chain Fv antibody construct.
Pavlinkova G; Colcher D; Booth BJ; Goel A; Batra SK
Cancer Immunol Immunother; 2000 Jul; 49(4-5):267-75. PubMed ID: 10941910
[TBL] [Abstract][Full Text] [Related]
42. A human/mouse chimeric monoclonal antibody against intercellular adhesion molecule-1 for tumor radioimmunoimaging.
Yamamura M; Hinoda Y; Sasaki S; Tsujisaki M; Oriuchi N; Endo K; Imai K
Jpn J Cancer Res; 1996 Apr; 87(4):405-11. PubMed ID: 8641973
[TBL] [Abstract][Full Text] [Related]
43. Recombinant mouse/human chimeric anti-colorectal carcinoma antibody cACT19.
Xiang J; Moyana T; Liu E
Hum Antibodies Hybridomas; 1994; 5(3-4):105-15. PubMed ID: 7756575
[TBL] [Abstract][Full Text] [Related]
44. A mouse/human chimeric anti-(ganglioside GD3) antibody with enhanced antitumor activities.
Shitara K; Kuwana Y; Nakamura K; Tokutake Y; Ohta S; Miyaji H; Hasegawa M; Hanai N
Cancer Immunol Immunother; 1993 Jun; 36(6):373-80. PubMed ID: 8500110
[TBL] [Abstract][Full Text] [Related]
45. Preparation of human IgG and IgM monoclonal antibodies for MK-1/Ep-CAM by using human immunoglobulin gene-transferred mouse and gene cloning of their variable regions.
Kuroki M; Yamada H; Shibaguchi H; Hachimine K; Hirose Y; Kinugasa T; Ishida I; Kuroki M
Anticancer Res; 2005; 25(6A):3733-9. PubMed ID: 16302733
[TBL] [Abstract][Full Text] [Related]
46. Construction and expression of a mouse-human chimeric antibody against human tumor necrosis factor-alpha.
Nagahira K; Fukuda Y; Nasu T; Kawashima H; Noguchi C; Kurihara T; Oikawa S; Nakanishi T
Immunol Lett; 1998 Dec; 64(2-3):139-44. PubMed ID: 9870665
[TBL] [Abstract][Full Text] [Related]
47. Expression and characterization of a mouse/human chimeric antibody specific for EGF receptor.
Ferrer C; Anastasi AM; Di Massimo AM; Bullo A; Di Loreto M; Raucci G; Pacilli A; Rotondaro L; Mauro S; Mele A; De Santis R
J Biotechnol; 1996 Nov; 52(1):51-60. PubMed ID: 9025323
[TBL] [Abstract][Full Text] [Related]
48. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
Prewett M; Huber J; Li Y; Santiago A; O'Connor W; King K; Overholser J; Hooper A; Pytowski B; Witte L; Bohlen P; Hicklin DJ
Cancer Res; 1999 Oct; 59(20):5209-18. PubMed ID: 10537299
[TBL] [Abstract][Full Text] [Related]
49. Construction and characterization of chimeric and humanized forms of a broadly neutralizing monoclonal antibody to HIV-1.
Major JG; Liou RS; Sun LK; Yu LM; Starnes SM; Fung MS; Chang TW; Chang NT
Hum Antibodies Hybridomas; 1994; 5(1-2):9-17. PubMed ID: 7858187
[TBL] [Abstract][Full Text] [Related]
50. Development of antiangiogenin peptide using a phage-displayed peptide library.
Gho YS; Lee JE; Oh KS; Bae DG; Chae CB
Cancer Res; 1997 Sep; 57(17):3733-40. PubMed ID: 9288781
[TBL] [Abstract][Full Text] [Related]
51. Construction of a chimeric antibody with therapeutic potential for cancers which overexpress c-erbB-2.
Liu HL; Parkes DL; Langton BC; Xuan JA; Longhi M; Elliger SS; Chao LA; McGrogan MP; Brandis JW; Shawver LK
Biochem Biophys Res Commun; 1995 Jun; 211(3):792-803. PubMed ID: 7598708
[TBL] [Abstract][Full Text] [Related]
52. Molecular cloning of a human monoclonal antibody reactive to ganglioside GM3 antigen on human cancers.
Hoon DS; Wang Y; Sze L; Kanda H; Watanabe T; Morrison SL; Morton DL; Irie RF
Cancer Res; 1993 Nov; 53(21):5244-50. PubMed ID: 7916649
[TBL] [Abstract][Full Text] [Related]
53. "Superhumanized" antibodies: reduction of immunogenic potential by complementarity-determining region grafting with human germline sequences: application to an anti-CD28.
Tan P; Mitchell DA; Buss TN; Holmes MA; Anasetti C; Foote J
J Immunol; 2002 Jul; 169(2):1119-25. PubMed ID: 12097421
[TBL] [Abstract][Full Text] [Related]
54. cDNA sequence analysis of monoclonal antibody FU-MK-1 specific for a transmembrane carcinoma-associated antigen, and construction of a mouse/human chimeric antibody.
Arakawa F; Yamamoto T; Kanda H; Watanabe T; Kuroki M
Hybridoma; 1999 Apr; 18(2):131-8. PubMed ID: 10380012
[TBL] [Abstract][Full Text] [Related]
55. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells.
Neumaier M; Shively L; Chen FS; Gaida FJ; Ilgen C; Paxton RJ; Shively JE; Riggs AD
Cancer Res; 1990 Apr; 50(7):2128-34. PubMed ID: 2107969
[TBL] [Abstract][Full Text] [Related]
56. Engineering a humanized bispecific F(ab')2 fragment for improved binding to T cells.
Rodrigues ML; Shalaby MR; Werther W; Presta L; Carter P
Int J Cancer Suppl; 1992; 7():45-50. PubMed ID: 1428403
[TBL] [Abstract][Full Text] [Related]
57. Angiogenin single-chain immunofusions: influence of peptide linkers and spacers between fusion protein domains.
Newton DL; Xue Y; Olson KA; Fett JW; Rybak SM
Biochemistry; 1996 Jan; 35(2):545-53. PubMed ID: 8555226
[TBL] [Abstract][Full Text] [Related]
58. A small-molecule inhibitor of the ribonucleolytic activity of human angiogenin that possesses antitumor activity.
Kao RY; Jenkins JL; Olson KA; Key ME; Fett JW; Shapiro R
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10066-71. PubMed ID: 12118120
[TBL] [Abstract][Full Text] [Related]
59. Vectors for the expression of PCR-amplified immunoglobulin variable domains with human constant regions.
Walls MA; Hsiao KC; Harris LJ
Nucleic Acids Res; 1993 Jun; 21(12):2921-9. PubMed ID: 8332501
[TBL] [Abstract][Full Text] [Related]
60. Humanization and pharmacokinetics of a monoclonal antibody with specificity for both E- and P-selectin.
He XY; Xu Z; Melrose J; Mullowney A; Vasquez M; Queen C; Vexler V; Klingbeil C; Co MS; Berg EL
J Immunol; 1998 Jan; 160(2):1029-35. PubMed ID: 9551944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
